GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Check-Cap Ltd (NAS:CHEK) » Definitions » 12-1 Month Momentum %

Check-Cap (Check-Cap) 12-1 Month Momentum % : 46.64% (As of Apr. 26, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Check-Cap 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-04-26), Check-Cap's 12-1 Month Momentum % is 46.64%.

The industry rank for Check-Cap's 12-1 Month Momentum % or its related term are showing as below:

CHEK's 12-1 Month Momentum % is ranked better than
88.61% of 237 companies
in the Medical Diagnostics & Research industry
Industry Median: -17.44 vs CHEK: 46.64

Competitive Comparison of Check-Cap's 12-1 Month Momentum %

For the Diagnostics & Research subindustry, Check-Cap's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Check-Cap's 12-1 Month Momentum % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Check-Cap's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Check-Cap's 12-1 Month Momentum % falls into.



Check-Cap  (NAS:CHEK) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Check-Cap  (NAS:CHEK) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Check-Cap 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Check-Cap's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Check-Cap (Check-Cap) Business Description

Traded in Other Exchanges
Address
29 Abba Hushi Avenue, Check-Cap Building, P.O. Box 1271, Isfiya, ISR, 3009000
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.